Renhe Pharmacy Co.,Ltd (000650.SZ)
- Previous Close
5.50 - Open
5.45 - Bid 5.52 x --
- Ask 5.53 x --
- Day's Range
5.50 - 5.58 - 52 Week Range
5.10 - 7.03 - Volume
20,482,383 - Avg. Volume
15,195,201 - Market Cap (intraday)
7.728B - Beta (5Y Monthly) 0.59
- PE Ratio (TTM)
16.24 - EPS (TTM)
0.34 - Earnings Date --
- Forward Dividend & Yield 0.20 (3.62%)
- Ex-Dividend Date Jul 8, 2024
- 1y Target Est
--
Renhe Pharmacy Co.,Ltd produces and sells pharmaceutical products. It offers Chinese and western medicines and raw materials; and health-related products, including oral solid preparations and liquid preparations, large-volume and small-volume injections, external lotions, liniments, suppositories, ointments, and other dosage forms of drugs and health-related products. The company was founded in 1996 and is headquartered in Nanchang, China.
www.renheyaoye.com5,394
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: 000650.SZ
View MorePerformance Overview: 000650.SZ
Trailing total returns as of 5/23/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 000650.SZ
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 000650.SZ
View MoreValuation Measures
Market Cap
7.73B
Enterprise Value
4.22B
Trailing P/E
16.42
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.01
Price/Book (mrq)
1.22
Enterprise Value/Revenue
1.10
Enterprise Value/EBITDA
5.57
Financial Highlights
Profitability and Income Statement
Profit Margin
12.27%
Return on Assets (ttm)
5.30%
Return on Equity (ttm)
8.00%
Revenue (ttm)
3.82B
Net Income Avi to Common (ttm)
468.92M
Diluted EPS (ttm)
0.34
Balance Sheet and Cash Flow
Total Cash (mrq)
3.84B
Total Debt/Equity (mrq)
0.04%
Levered Free Cash Flow (ttm)
197.74M